HIV cholesterol showdown: which statin works best?
NCT ID NCT00117494
First seen Apr 18, 2026 · Last updated May 09, 2026 · Updated 3 times
Summary
This study tested two statins, rosuvastatin and pravastatin, in 86 people with HIV who had high cholesterol and were taking antiretroviral drugs. The goal was to see which drug lowers LDL (bad) cholesterol more safely and effectively over 45 days. Results help doctors choose the best statin for managing heart disease risk in HIV patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
service de Médecine Interne Hopital Hotel Dieu
Paris, 75004, France
Conditions
Explore the condition pages connected to this study.